Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.1%.

  • Amphastar Pharmaceuticals' Return on Capital Employed fell 500.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.15% for FY2024, which is 700.0% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.1% for Q3 2025, which was down 500.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Return on Capital Employed ranged from a high of 0.18% in Q1 2023 and a low of 0.03% during Q1 2021
  • For the 5-year period, Amphastar Pharmaceuticals' Return on Capital Employed averaged around 0.13%, with its median value being 0.15% (2023).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 1100bps in 2022, then plummeted by -500bps in 2025.
  • Amphastar Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.13% in 2021, then skyrocketed by 34bps to 0.17% in 2022, then dropped by -10bps to 0.15% in 2023, then fell by -2bps to 0.15% in 2024, then dropped by -29bps to 0.1% in 2025.
  • Its last three reported values are 0.1% in Q3 2025, 0.13% for Q2 2025, and 0.14% during Q1 2025.